Is restoring epicardial flow enough in STEMI? Supersaturated oxygen (SSO2) therapy could represent the next frontier in myocardial salvage. Excited to share our latest JACC: Case Reports publication doi.org/10.1016/j.jaccas.202…

📖Formal cost-effectiveness analysis demonstrates that supersaturated oxygen #SSO2 therapy for patients with acute anterior #STEMI is a cost-effective adjunct to primary #PCI from the perspective of the US healthcare system. ➡️jscai.org/article/S2772-9303… @djc795 @nmbutala

Standing room only at #SCAI2026 Symposium: The New Era of Myocardial Perfusion in STEMI. What are the key takeaways from the symposium? ➡️Epicardial reperfusion (TIMI 3 flow) is necessary but not sufficient. Opening the artery is not the same as restoring the myocardium. ➡️ #STEMI outcomes are not defined by DTB times alone. Time to Myocardial Protection matters. ➡️To change outcomes in STEMI, treat the microvasculature, not just epicardial artery - @FarazHaroonMD 🎯Complete the Reperfusion: Epicardial Reperfusion Microvascular Reperfusion 🫀 SSO2 Therapy targets the microvasculature through its MOA: (Kloner et al: bit.ly/4n9RYm1) SSO2 Therapy has been shown to reduce infarct size & relieve MVO post-PCI in LAD STEMI w/o impacting DTB times: bit.ly/4np3g61 Learn more at TherOx.com See IFU: bit.ly/47sACwm

Phenomenal talk by Dr Sandeep Nathan on overview of SSO2 therapy for complete re perfusion. 👏🫶 🌟 Are we missing coronary MVO? 🌟 SSO2 adjunctive Tx - infarct size ⬇️ 🌟 SSO2 trials - AMIHOT 1, 2 and IC HOT 🌟 Upcoming trial - SSCORE study #SCAI2026 @SCAI ♥️

#SCAI2026 kicks off today in Montreal, Canada. Advancing STEMI care is on the agenda – join our lunch symposium about Completing the Reperfusion in #STEMI on Saturday, April 25 at 11:55am in Room 510B. ➡️Visit Zoll Booth 316 to learn how SSO2 Therapy can support your LAD STEMI patients post-PCI. See IFU: bit.ly/47sACwm

📖💡1. Pilot anterior #STEMI: SSO2 halved angio-IMR; benefit concentrated when baseline angio-IMR >40. Toward targeted SSO2 post-PCI. #STEMI #PCI 2. SSO2 cut angio-IMR ~50% in anterior STEMI; biggest gains when baseline >40—signal for stratified use. #Microcirculation #SupersaturatedOxygen ➡️ jscai.org/article/S2772-9303… @GBaronerochette

Do any of you do SuperSaturated O2 (SSO2) for anterior STEMI? ➡️ What are your thoughts on this therapy?

SSO2 is the only FDA-approved adjunct to PCI for LAD STEMI, it’s the only therapy in this space that has ever reduced infarct size in a randomized trial, and the 1-year outcomes data from IC-HOT shows it translates to meaningful reductions in death and HF.

Today at #CRT2026: Don’t miss these opportunities to learn how SSO2 Therapy can support your #STEMI patients. @TCShuey_DO @djc795 @GreggWStone See IFU: bit.ly/47sACwm

Truly blessed to have received 2nd place demonstrating our findings with @ZOLLTherOx in high risk anterior MI patients with cardiogenic shock @HoustonShockHSS #CardiogenicShock #CardioFellow #SSO2

Truly blessed to have received 2nd place demonstrating our findings with @ZOLLTherOx in high risk anterior MI patients with cardiogenic shock @HoustonShockHSS #CardiogenicShock #CardioFellow #SSO2

What's trending in #STEMI care? Doing More for STEMI has been top of mind for interventional cardiologists and it's high on the agenda at #CRT2026. ✅ SSO2 Therapy is the only FDA-approved therapy for infarct size reduction in LAD STEMI. ➡️ Check out these insightful sessions on March 8 with the industry experts - Jeff Chambers, @djc795 @GreggWStone, @TCShuey_DO - to learn how SSO2 Therapy can support your STEMI patients. See IFU: bit.ly/47sACwm

Presented our experience at Technology and Heart Failure Therapeutics (THT) 2026. In STEMI with SCAI C–D cardiogenic shock, patients treated with SSO₂ after primary PCI (n=11) showed: • 100% 30-day survival • LVEF improvement from 23% → 48% at 5 months Promising signal — prospective randomized trial warranted to validate these findings. Grateful for the mentorship of Dr. Rajiv Jauhar (@stentdoc1). @NorthwellHealth @SCAI @crfheart #tht26 #cardiotwitter #stemi #cardiogenicshock #InterventionalCardiology #scai #sso2

Noctua eleva el listón con el NF-A14x25 G2 PWM chromax.black. 🖤 Rendimiento de próxima gen en 140mm, por fin en negro. Tecnología Sterrox, SSO2 y un diseño acústico avanzado para el mejor flujo de aire/silencio. El nuevo rey para builds de alto rendimiento. #Noctua

What’s new in STEMI management? Dr. Tim Henry is leading conversations at #SIF2026 @SIFCardiology about the state of #STEMI, novel & emerging therapies, including the FDA-approved SSO2 therapy and how it helps to complete reperfusion post-PCI through improved microvascular function and myocardial recovery. Epicardial Reperfusion Microvascular Reperfusion = #CompleteReperfusion🫀 ✅SSO2 is safe, effective and simple to use. Learn more at TherOx.com Refer to IFU for additional info: bit.ly/47sACwm

⏰Reminder: This morning at @SIFCardiology, stop by Cases over Coffee with Dr. Tim Henry to discuss how SSO2 therapy can impact #STEMI outcomes. See IFU: bit.ly/47sACwm #CardioTwitter #SIF2026

Henry Mayo Newhall Hospital is one of the first hospitals in Southern California to improve treatment of “widowmaker” heart attack patients with SuperSaturated Oxygen (SSO2) Therapy, the first and only FDA-approved therapy that could reduce muscle... hometownstation.com/santa-cl…

เรื่องประกันสังคม ในเมื่อความคิดไม่ตรงกัน เราก็แยกเป็นสองกองไปเลยซิครับ แล้วให้เลือกว่าใครจะเข้ากองไหน เช่น SSO1, SSO2 กองแรกให้เป็นเหมือนเดิม ให้ราชการบริหาร ส่วนกองที่สองก็ให้เอกชนบริหาร จากนั้นเราก็มาดูกัน ใครเลือกผิดต้องรับชะตากรรมตัวเอง คนที่เลือกถูกก็ไม่ต้องไปรับกรรมคนอื่น

Heart Failure accounts for >1MM annual hospital admissions per year* ❓What are the implications of #STEMI on #heartfailure (HF)? ❓What can Interventional Cardiologists do to support STEMI patients? In this thread, we’ll look 🔎at the current state of heart failure and how adjunctive therapies such as SSO2 Therapy may #CompleteReperfusion🫀post-PCI to improve the prognosis of STEMI. *bit.ly/4ovrVqu See IFU: bit.ly/47sACwm 1/8